Tvardi Therapeutics, Inc. (TVRD)
3.14
-0.01
(-0.32%)
USD |
NASDAQ |
May 01, 16:00
3.13
-0.01
(-0.32%)
Pre-Market: 20:00
Tvardi Therapeutics Market Cap : 29.46M for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 862.01B |
| Nektar Therapeutics | 1.496B |
| ACADIA Pharmaceuticals, Inc. | 3.742B |
| Agenus, Inc. | 147.45M |
| Alnylam Pharmaceuticals, Inc. | 39.51B |
Market Cap Related Metrics
| PS Ratio | 8.781 |
| Price to Book Value | 1.406 |
| Price | 3.14 |
| Earnings Yield | -178.0% |